Published in Science on October 20, 1978
Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor. J Exp Med (1984) 2.00
SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem (2009) 1.39
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology (2002) 1.36
Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br J Pharmacol (1996) 1.10
Prostaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes. Infect Immun (1979) 1.04
Retinoids as regulators of macrophage function. Immunology (1980) 1.03
Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon. J Exp Med (1985) 1.02
Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages. Cell Commun Signal (2012) 1.02
Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology (1994) 1.02
Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes. Proc Natl Acad Sci U S A (2003) 0.98
Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation. Immunology (1993) 0.97
Establishment of the interferon-mediated antiviral state: role of fatty acid cyclooxygenase. Proc Natl Acad Sci U S A (1980) 0.92
Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages. Clin Exp Immunol (1980) 0.87
Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br J Cancer (1980) 0.85
Eicosanoid production by peritoneal and splenic macrophages in mice depleted of bone marrow by 89Sr. Am J Pathol (1987) 0.81
Thromboxane generation by human monocytes enhances platelet function. J Exp Med (1986) 0.81
Enhancement of B-cell translocation gene-1 expression by prostaglandin E2 in macrophages and the relationship to proliferation. Immunology (1997) 0.80
Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. Clin Exp Immunol (1984) 0.78
Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients. Ann Surg (1982) 0.78
Subcellular localization of the PGE2 synthesis activity in mouse resident peritoneal macrophages. J Exp Med (1984) 0.77
Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment. BMC Complement Altern Med (2013) 0.77
Antiviral and interferon-inducing properties of interferon inducers administered with prostaglandins. Antimicrob Agents Chemother (1980) 0.75
Macrophage functions are regulated by murine decidual and tumor extracellular matrices. J Clin Invest (1992) 0.75
Cancer immunotherapy: potential involvement of mediators. Mediators Inflamm (1997) 0.75
Selective induction of metabolic activation programs in peritoneal macrophages by lipopolysaccharide substructures. Infect Immun (1991) 0.75
Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth. J Exp Med (1986) 0.75
Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development (2000) 3.70
Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod (2000) 3.33
LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res (1997) 2.83
Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo. Dev Biol (1997) 2.42
Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature. Lung Cancer (2000) 2.11
Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis. Dev Biol (1983) 2.03
Functional identity between murine gamma interferon and macrophage activating factor. Nature (1983) 1.89
Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst (1974) 1.86
Preimplantation development of mouse embryos in KSOM: augmentation by amino acids and analysis of gene expression. Mol Reprod Dev (1995) 1.83
Histone macroH2A1 is concentrated in the inactive X chromosome of female preimplantation mouse embryos. Development (2000) 1.66
Stimulation of humoral and cellular antibody formation in mice by poly Ir:Cr. Proc Soc Exp Biol Med (1970) 1.64
Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant. Cancer Res (1973) 1.60
Interferon: an inducer of macrophage activation by polyanions. Science (1977) 1.59
Apoptosis during mouse blastocyst formation: evidence for a role for survival factors including transforming growth factor alpha. Biol Reprod (1997) 1.55
A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res (1991) 1.51
RNAi in mouse oocytes and preimplantation embryos: effectiveness of hairpin dsRNA. Biochem Biophys Res Commun (2001) 1.49
Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child (1980) 1.48
Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney). Int J Cancer (1968) 1.47
Maturation of mouse oocytes in serum-free medium. Hum Reprod (1996) 1.40
Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA). Adv Enzyme Regul (1998) 1.37
Diffuse fasciitis with eosinophilia. A clinicopathologic study. Am J Med (1980) 1.31
Expression of MSY2 in mouse oocytes and preimplantation embryos. Biol Reprod (2001) 1.30
Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes. Dev Biol (1994) 1.28
Embryonic genome activation. Front Biosci (2001) 1.28
Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1/CD31) in the mouse blastocyst. Dev Biol (2001) 1.27
Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Cancer Res (1975) 1.25
Regulation of zygotic gene activation in the preimplantation mouse embryo: global activation and repression of gene expression. Biol Reprod (2001) 1.24
Involvement of cAMP-dependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation. Dev Biol (1986) 1.23
Functional and morphologic characteristics of interferon-treated macrophages. Cell Immunol (1978) 1.23
Mouse sperm-egg plasma membrane interactions: analysis of roles of egg integrins and the mouse sperm homologue of PH-30 (fertilin) beta. J Cell Sci (1995) 1.21
Characterization of the binding of recombinant mouse sperm fertilin beta subunit to mouse eggs: evidence for adhesive activity via an egg beta1 integrin-mediated interaction. Dev Biol (1997) 1.20
Regulation of gene expression in the mouse oocyte and early preimplantation embryo: developmental changes in Sp1 and TATA box-binding protein, TBP. Development (1994) 1.20
Splitting of human thyroglobulin. I. Reduction and alkylation. Clin Exp Immunol (1969) 1.19
Analysis of gene expression in the preimplantation mouse embryo: use of mRNA differential display. Proc Natl Acad Sci U S A (1994) 1.19
Specific macrophage immunity to vaccinia virus: macrophage-virus interaction. Infect Immun (1972) 1.19
Combined chemoimmunostimulation therapy against murine leukemia. Cancer Res (1972) 1.18
Expression patterns of novel genes during mouse preimplantation embryogenesis. Mol Reprod Dev (1994) 1.18
Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J Med Chem (1996) 1.18
Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol (1985) 1.17
Egg-induced modifications of the zona pellucida of mouse eggs: effects of microinjected inositol 1,4,5-trisphosphate. Dev Biol (1989) 1.16
Active Site of alpha-Chymotrypsin Activation by Association-Desolvation. Proc Natl Acad Sci U S A (1970) 1.16
Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis. Cancer Chemother Pharmacol (1997) 1.15
Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication. Cancer Res (1970) 1.14
Fetuin inhibits zona pellucida hardening and conversion of ZP2 to ZP2f during spontaneous mouse oocyte maturation in vitro in the absence of serum. Biol Reprod (1990) 1.12
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis. Ann Oncol (2000) 1.12
A simple micro method for the direct determination of delta-amino (14C) levulinic acid production in murine spleen and liver homogenates. Biochim Biophys Acta (1970) 1.11
Reporter gene expression in G2 of the 1-cell mouse embryo. Dev Biol (1993) 1.11
Temporally restricted spatial localization of acetylated isoforms of histone H4 and RNA polymerase II in the 2-cell mouse embryo. Development (1995) 1.09
Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Cancer Res (1985) 1.08
Biochemical studies of mammalian oogenesis: synthesis and stability of various classes of RNA during growth of the mouse oocyte in vitro. Dev Biol (1981) 1.08
Stage-specific expression of a family of proteins that are major products of zygotic gene activation in the mouse embryo. Dev Biol (1991) 1.08
Igf2r and Igf2 gene expression in androgenetic, gynogenetic, and parthenogenetic preimplantation mouse embryos: absence of regulation by genomic imprinting. Genes Dev (1994) 1.08
Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium. J Immunol Methods (1984) 1.08
Spontaneous activation of ovulated mouse eggs: time-dependent effects on M-phase exit, cortical granule exocytosis, maternal messenger ribonucleic acid recruitment, and inositol 1,4,5-trisphosphate sensitivity. Biol Reprod (1997) 1.07
Acquisition of a transcriptionally permissive state during the 1-cell stage of mouse embryogenesis. Dev Biol (1992) 1.07
Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. Antiviral Res (1994) 1.07
Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. Cancer Res (1978) 1.05
Biochemical studies of mammalian oogenesis: Protein synthesis during oocyte growth and meiotic maturation in the mouse. J Cell Sci (1977) 1.05
Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res (1990) 1.05
Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment. Antimicrob Agents Chemother (1982) 1.05
Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic. J Interferon Res (1982) 1.05
Inhibition of RNA-dependent DNA polymerase of avian myeloblastosis virus by pyran copolymer. Proc Natl Acad Sci U S A (1974) 1.04
Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity. J Immunol (1985) 1.03
Blastocoel expansion in the preimplantation mouse embryo: role of extracellular sodium and chloride and possible apical routes of their entry. Dev Biol (1989) 1.02
In vitro stimulation of spleen cell cultures by poly I: poly C and levamisole. Cell Immunol (1974) 1.02
Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. Eur J Cancer (2001) 1.02
DNA replication in the 1-cell mouse embryo: stimulatory effect of histone acetylation. Zygote (1999) 1.02
Role of folic acid in modulating the toxicity and efficacy of the multitargeted antifolate, LY231514. Anticancer Res (1998) 1.01
Splitting of human thyroglobulin. II. Enzymatic digestion. Clin Exp Immunol (1969) 1.01
Specific changes in the pattern of protein synthesis during meiotic maturation of mammalian oocytes in vitro. Proc Natl Acad Sci U S A (1977) 1.01
The clinical picture of primary Sjögren's syndrome: a retrospective study. J Rheumatol (1983) 1.01
Intercellular communication between granulosa cells and mouse oocytes: existence and possible nutritional role during oocyte growth. Dev Biol (1982) 1.01
Characterization of downstream Ras signals that induce alternative protease-dependent invasive phenotypes. J Biol Chem (1997) 1.00
Acquisition of meiotic competence in mouse oocytes: absolute amounts of p34(cdc2), cyclin B1, cdc25C, and wee1 in meiotically incompetent and competent oocytes. Biol Reprod (2000) 1.00
Effective antiviral therapy of two murine leukemias with an interferon-inducing synthetic carboxylate copolymer. Int J Cancer (1969) 0.99
Potentiation of murine sarcoma virus (Harvey) (Moloney) oncogenicity in lactic dehydrogenase-elevating virus-infected mice. Proc Soc Exp Biol Med (1971) 0.99
Roles of heterotrimeric and monomeric G proteins in sperm-induced activation of mouse eggs. Development (1994) 0.99
Developmental change in TATA-box utilization during preimplantation mouse development. Dev Biol (2000) 0.98
Regulation of mouse oocyte maturation: effect of elevating cumulus cell cAMP on oocyte cAMP levels. Biol Reprod (1985) 0.98
Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro. J Reticuloendothel Soc (1974) 0.98
THE ACTIVE SITE IN alpha-CHYMOTRYPSIN: METHYL 3,4-DIHYDROISOCOUMARIN-3-CARBOXYLATE I. Proc Natl Acad Sci U S A (1967) 0.98
Selective neutralization by antiinterferon globulin of macrophage activation by L-cell interferon, Brucella abortus ether extract, Salmonella typhimurium lipopolysaccharide, and polyanions. Cell Immunol (1979) 0.97
Splitting of human thyroglobulin. IV. The antigenicity of the pepsin-derived fragments. Clin Exp Immunol (1977) 0.97
Cell line derived from a murine sarcoma virus (Moloney Pseudotype)-induced tumor: cultural, antigenic, and virological properties. Appl Microbiol (1971) 0.97
Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum. Cancer Res (1969) 0.97
Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor). Dev Biol (2000) 0.97
Sulfonimidamide analogs of oncolytic sulfonylureas. J Med Chem (1997) 0.96
Posttranscriptional regulation of cyclin A1 and cyclin A2 during mouse oocyte meiotic maturation and preimplantation development. Biol Reprod (2001) 0.96
Program of early development in the mammal: changes in patterns and absolute rates of tubulin and total protein synthesis during oogenesis and early embryogenesis in the mouse. Dev Biol (1979) 0.96
Dose responsiveness and variation among inbred strains of mice in production of interferon after treatment with poly (I)-poly (C) (poly-D-lysine) complexes. Appl Microbiol (1971) 0.96
Assessment of DNA damage in individual hamster embryos by comet assay. Mol Reprod Dev (1999) 0.95
A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors. Cancer Res (1994) 0.95
Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses. Cancer Res (1968) 0.94